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C40 J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 6 , N O . 1 6 , S U P P L S , 2 0 1 512 weeks (model group vs control group: 0.83570.0235units/ml vs
0.18700.0191units/ml). There were strong positive signals of PKCa
both in the intima and in the media closely abuted with the intima.
Further in vitro experiment discovered that modiﬁed LDL signiﬁ-
cantly increased cytomembrane PKC activity in HASMC, HAEC and
THP-1, and that 100nmol/l PMA (PKC agonist) could synergistically
enhance the expressions of ICAM-1 and ezrin in the presence of
oxidized LDL (oxLDL, a key modiﬁed LDL); However, it reduced the
content of I-kBa. Together with oxLDL, PMA stimulated the adhesion
ability of endothelial cells with monocytes. 300nmol/lCalphostin C
(PKC inhibitor) could ultimately reverse the effects induced by 50mg/
ml oxLDL, that is to say, PKC activity, the expression of ICAM-1 and
ezrin, and the adhesion ability of HAEC cells were down-regulated,
respectively, whereas the content of I-kBa was increased. Similarly
with the effects of oxLDL, enzymatically modiﬁed LDL (E-LDL, a key
modiﬁed LDL) increased the adhesion ability of endothelial cells with
monocytes in a dose-dependent manner and the ideal dose of E-LDL
is 20-40mg/ml. 200-400nml/l Calphostin C ultimately reverse the
effects induced by E-LDL. ICAM-1 and I-kBa may mediate the corre-
sponding pathological process.
CONCLUSIONS The pathway of PMA/Calphostin C - PKC- NF-kB/I-
kB -ICAM-1-Adherence may be an important one through which
the adherent information was conveyed and integrated. In addi-
tion, the pathway adhesion molecules-ezrin-cytoskeleton may
enhance the adhesion interaction of endothelial cells with mono-
cytes. Calphostin C could effectively inhibited the increase of the
adhesion ability of endothelial cells with monocytes induced by
modiﬁed LDL.GW26-e0807
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OBJECTIVES The aim of this study was to explore multimodality
molecular imaging to monitor transplanted stem cells with a triple-
fused reporter gene in acute myocardial infarction rat models.
METHODS Rat myocardial infarction was established by ligating the
left anterior descending coronary artery. A recombinant adenovirus
carrying TGF (Ad5-TGF) was constructed. After transfection with
Ad5-TGF, 5  10(6) bone marrow mesenchymal stem cells (BMSCs)
were transplanted into the anterior wall of the left ventricle
(n ¼ 14). Untransfected BMSCs were as controls (n ¼ 8). MicroPET/
CT, ﬂuorescence and bioluminescence imaging were performed.
Continuous images were obtained at day 2, 3 and 7 after trans-
plantation with all three imaging modalities and additional images
were performed with bioluminescence imaging until day 15 after
transplantation.
RESULTS High signals in the heart area were observed using
microPET/CT, ﬂuorescence and bioluminescence imaging of in-
farcted rats injected with Ad5-TGF-transfected BMSCs, whereas no
signals were observed in controls. Semi-quantitative analysis showed
the gradual decrease of signals in all three imaging modalities with
time. Immunohistochemistry assays conﬁrmed the location of the
TGF protein expression was the same as the site of stem cell-speciﬁc
marker expression, suggesting that TGF tracked the stem cells in
situ.
CONCLUSIONS TGF could be used as a reporter gene to monitor stem
cells in a myocardial infarction model by multimodality molecular
imaging.
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OBJECTIVES miR-126 is considered to play an active role in car-
dioprotection against ischemia/reperfusion (I/R) injury, as studies
suggest that it facilitates vascular regeneration and ameliorates
myocardial I/R injury by modulating angiogenic signaling. In thisstudy, the critical role of miR-126 in cardiomyocyte survival and the
underlying molecular mechanism were investigated.
METHODS Male Wistar rats were randomly divided into sham opera-
tion group and I/R group (in which the left anterior descending cor-
onary artery of the rats were ligated for 30 min and then reperfused
for 120 min). Lentivirus expressing miR-126 (LmiR-126) was con-
structed and transfected into rat through the right common carotid
artery. Western blotting and quantitative PCR methods were applied
to detect protein and mRNA expressions. Myocardial apoptosis and
infarct size were analyzed by in situ apoptosis assay and triphe-
nyltetrazolium chloride (TTC) staining, respectively.
RESULTS Our study demonstrated that the expression of miR-126
was decreased in I/R group compared with sham operation group
(p<0.01). Stretch or enforced expression of miR-126 signiﬁcantly
decreased I/R-induced myocardial infarct size by 42% and attenu-
ated I/R-induced myocardial apoptosis, together with down-regu-
lation of glycogen synthase kinase 3 beta (GSK-3b) (p<0.05). The
results of luciferase assays suggested that GSK-3b may be a direct
target of miR-126. Knockdown of GSK-3b inhibited cell apoptosis
and afforded cardioprotection during I/R injury, while its over-
expression abolished the effects of miR-126. In addition, miR-126
increased both protein and mRNA levels of b-catenin, which is the
downstream effector of GSK-3b in Wnt/b-catenin signaling pathway,
and subsequently elevated the expressions of b-catenin targets
cyclin D1 and c-Myc.
CONCLUSIONS These ﬁndings illustrated that miR-126 played
an important role in cardioprotection against I/R injury through tar-
geting GSK-3b and subsequently activating Wnt/b-catenin signaling
pathway.GW26-e1435
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OBJECTIVES Atrial ﬁbrosis is a major contributing factor of atrial
ﬁbrillation (AF). Tanshinone IIA (TSN) is a lipophilic diterpene
extracted from the Chinese herb Salvia miltiorrhiza Bunge with anti-
ﬁbrotic effect. We used isoproterenol-induced myocardial infarction
(MI) rats together with transesophageal programmed electrical stim-
ulation AF inducing technology to investigate the effects of TSN on AF
and the underlying mechanisms.
METHODS MI rat model was induced by isoproterenol. One week after
the ﬁrst injection, 100 mg/Kg/d TSN was gavaged for 4 weeks. AF
inducibility and duration were detected by transesophageal pro-
grammed electrical stimulation AF inducing technology. The expres-
sion of I and III collagen and the change of MMP-9/TIMP-1 balance in
left atrial were measured by western blot.
RESULTS After 2 hours of injection isoproterenol, the ST segment
elevated and serum CK-MB levels increased. Four weeks after the
administration of TSN, the AF inducibility was lower than the MI
group (47.1% in TSN vs. 70.6% in MI) and the AF duration was reduced
(88.1-257.4s in TSN vs. 441.5-1317.5s in MI, P <0.05). Type I (0.950.08
in TSN vs. 1.690.14 in MI, P<0.05) and III (1.950.20 in TSN vs.
3.190.36 in MI, P<0.05) collagen in left atrium were decreased in
administration group, compared with MI group. The matrix metal-
loproteinase (MMP)-9 and tissue inhibitor of metalloproteinase 1
(TIMP-1) protein levels were lower than MI group, MMP-9/TIMP-1
ratio (0.20 in TSN vs. 0.27 in MI) decreased.
CONCLUSIONS TSN reduces the inducibility rate and duration of AF
after MI by inhibiting left atrial ﬁbrosis via regulating MMP-9 / TIMP-1
balance.GW26-e1522
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OBJECTIVES Cardiac ﬁbrosis is a common feature of advanced
coronary heart disease and is also a hallmark of heart diseases.
